312 results on '"Glioblastomas -- Care and treatment"'
Search Results
2. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
3. Investigators at Humanitas University Report New Data on Muscular Atrophy (Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis)
4. National Cancer Institute (NCI) Researchers Update Understanding of siRNA-Based Therapy (Improving Radiation Response in Glioblastoma Using ECO/siRNA Nanoparticles Targeting DNA Damage Repair)
5. Studies from Virginia Polytechnic Institute and State University Provide New Data on Glioblastomas (Modulating microenvironments for treating glioblastoma)
6. Investigators at University of Perugia Target Glioblastomas [Effect of 1a,25(OH)2 Vitamin D3 in Mutant P53 Glioblastoma Cells: Involvement of Neutral Sphingomyelinase1]
7. Reports from Department of Medical Oncology Advance Knowledge in Neurofibromatosis Type 1 (Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis ...)
8. AIVITA Biomedical completes treatment of patients in phase 2 trial of AV-GBM-1 to treat glioblastoma
9. Researchers at Yonsei University College of Medicine Release New Data on Glioblastomas (One-Year Outcome of Multiple Blood-Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma)
10. Investigators at Masaryk Memorial Cancer Institute Report New Data on Glioblastomas (Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable)
11. University of Lisbon Researchers Publish New Data on Glioblastomas (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme)
12. Findings from University of Alabama Yields New Data on Glioblastomas (In Vitro Demonstration of Salinomycin As a Novel Chemotherapeutic Agent for the Treatment of Sox2-positive Glioblastoma Cancer Stem Cells)
13. Masaryk Memorial Cancer Institute Researchers Detail Findings in Glioblastomas (Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable)
14. Study Results from Rajiv Gandhi Cancer Institute and Research Center Provide New Insights into Glioblastomas (Pseudoprogression On Ga-68-prostate-specific Membrane Antigen-11 Pet/ct In a Treated Glioblastoma)
15. Report Summarizes Glioblastomas Study Findings from Imperial College London (Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid)
16. Recent Findings in Glioblastomas Described by Researchers from Federal University Sao Paulo (Management of elderly patients with glioblastoma: current status with a focus on the post-operative radiation therapy)
17. New Glioblastomas Findings from Nynke M. Kannegieter and Co-Authors Described (Multiomics profiling of paired primary and recurrent glioblastoma patient tissues)
18. Patient-derived glioblastoma cells (GBM) exhibit distinct biomechanical profiles associated with altered activity in the cytoskeleton regulatory pathway
19. New Findings in Glioblastomas Described from Shandong University (The Effect of Polysaccharides From Cibotium Barometz On Enhancing Temozolomide-induced Glutathione Exhausted In Human Glioblastoma U87 Cells, As Revealed By H-1 Nmr Metabolomics ...)
20. Studies from Masaryk Memorial Cancer Institute Provide New Data on Glioblastomas (Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade)
21. BerGenBio begins patient dosing in trial assessing selective AXL inhibitor bemcentinib in recurrent glioblastoma
22. Reports Outline Glioblastomas Study Results from Center for Genetic Engineering and Biotechnology (A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status)
23. Karolinska Institute Reports Findings in Glioblastomas (Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients)
24. Investigators from University of Kiel Report New Data on Glioblastomas (Macroscopic Silicone Microchannel Matrix for Tailored Drug Release and Localized Glioblastoma Therapy)
25. Reports by O. V. Zemskova and Co-Researchers Describe Recent Advances in Glioblastomas (Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy)
26. Data from Emory University Provide New Insights into Brain Cancer [The Longitudinal Imaging Tracker (Brics-lit): a Cloud Platform for Monitoring Treatment Response In Glioblastoma Patients]
27. I-Mab, Genexine receive China NMPA nod to begin phase 2 trial of TJ107/HyLeukin-7 in glioblastoma multiforme
28. Reports Outline Glioblastomas Study Findings from Institute of Radiation Medicine (The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme)
29. New Data from National Cancer Institute (NCI) Illuminate Findings in Glioblastomas (MGMT Status as a Clinical Biomarker in Glioblastoma)
30. Zai Lab receives China NMPA approval for Optune for glioblastoma
31. DelMar enrolls 22 patients in phase 2 study investigating adjuvant treatment of MGMT-unmethylated glioblastoma multiforme with VAL-083
32. Findings from Nanjing University Broaden Understanding of Glioblastomas (Pifithrin-mu Incorporated In Gold Nanoparticle Amplifies Pro-apoptotic Unfolded Protein Response Cascades To Potentiate Synergistic Glioblastoma Therapy)
33. Clinical Significance of Fractional Anisotropy Measured in Peritumoral Edema as a Biomarker of Overall Survival in Glioblastoma: Evidence Using Correspondence Analysis
34. Optimizing the Delivery of Antineoplastic Therapies to the Central Nervous System
35. New Data from Institute of Biomedical and Health Engineering Illuminate Findings in Glioblastomas (Ultrasound-Induced Blood-Brain-Barrier Opening Enhances Anticancer Efficacy in the Treatment of Glioblastoma: Current Status and Future Prospects)
36. Research Institute Researchers Describe Findings in Glioblastomas (Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres)
37. University Medical Center Ulm Researchers Update Knowledge of Glioblastomas (Temozolomide and Other Alkylating Agents in Glioblastoma Therapy)
38. Anticancer effects of FL34 through the inhibition of GLI1 in glioblastoma
39. Bayer treatment of glioblastoma multiforme granted orphan status
40. Findings from University of West Attica Provides New Data on Glioblastomas (Development of a New Theoretical Model for Blood-cnts Effective Thermal Conductivity Pertaining To Hyperthermia Therapy of Glioblastoma Multiform)
41. Medicenna Therapeutics completes enrollment in phase 2b study of MDNA55 to treat recurrent glioblastoma
42. New Glioblastomas Study Findings Have Been Reported by Investigators at University Hospital [Lomustine-temozolomide Combination Therapy Versus Standard Temozolomide Therapy In Patients With Newly Diagnosed Glioblastoma With Methylated Mgmt ...]
43. Findings from J. Chen and Co-Researchers in the Area of Glioblastomas Described (ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme)
44. Findings from University of Maryland Provides New Data on Alkylating Agents (Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction)
45. Reports on Life Science Findings from Massachusetts Institute of Technology Provide New Insights (Linking single-cell measurements of mass, growth rate, and gene expression)
46. Vaximm begins phase I/II trial with VXM01 oral T-cell immunotherapy in combo with Avelumab in glioblastoma
47. Recent Studies by M. Nieda and Co-Authors Add New Data to Glioblastomas Findings [Dendritic cells cross-talk with tumour antigen-specific CD8(+) T cells, V9T cells and V24NKT cells in patients with glioblastoma multiforme and in healthy donors]
48. Investigators at Department of Radiotherapy Zero in on Medulloblastoma (Radiation-induced glioblastoma with rhabdoid characteristics following treatment for medulloblastoma: A case report and review of the literature)
49. MediciNova granted orphan status for glioblastoma treatment
50. New Epidermal Growth Factors Study Findings Have Been Reported by Researchers at Ministry of Education (Connexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastoma)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.